HomeInsightsMarket Capitalization

Market Capitalization of Aarti Pharmalabs Ltd

Market Capitalization of Aarti Pharmalabs Ltd

stocks purchased

₹ 2.8 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

44.2 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Market Cap

₹ 5725.3 crore

Last updated on: Dec 26, 2024

Key Highlights

  • The Market Cap of Aarti Pharmalabs Ltd is ₹ 5725 crore as of 26 Dec 24 .
  • The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2023 to ₹ 3942 crore on March 2024 . This represents a CAGR of 25.85% over 2 years.
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 631.75 as of 26 Dec 15:30 .
  • The Dividend Payouts of Aarti Pharmalabs Ltd changed from ₹ 2 on Feb 16, 2024 to ₹ 1 on Jul 31, 2024 . This represents a CAGR of -29.29% over 2 years.

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Company Fundamentals for Aarti Pharmalabs Ltd

No data available

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Share Price

₹ 631.75

48.00 (8.22%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024631.75
24 Dec 2024583.75
23 Dec 2024578.55
20 Dec 2024570.6
19 Dec 2024572.25
18 Dec 2024565.1
17 Dec 2024584.35
16 Dec 2024602.85
13 Dec 2024606.85
12 Dec 2024601.65

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarti Pharmalabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Aarti Pharmalabs Ltd

No data available

No data available

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

* All values are in %

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Aarti Pharmalabs Ltd

No data available

* All values are in

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

News

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the ...

Read more

28 Oct 2024 17:31

News

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 Octobe...

Read more

22 Oct 2024 10:37

News

Aarti Pharmalabs to convene board meeting

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 5 August ...

Read more

30 Jul 2024 11:17

News

Aarti Pharmalabs schedules AGM

Aarti Pharmalabs announced that the 91th Annual General Meeting (AGM) of the company will ...

Read more

17 Jul 2024 09:30

News

CRISIL reaffirms ratings of Aarti Pharmalabs with 'positive' outlook

CRISIL stated that the ratings continue to reflect the established market position in the ...

Read more

27 Jun 2024 13:54

News

Aarti Pharmalabs Ltd leads losers in 'A' group

Colgate-Palmolive (India) Ltd, Jyothy Labs Ltd, Archean Chemical Industries Ltd and Aarti ...

Read more

15 May 2024 15:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Aarti Pharmalabs Ltd Market Cap

What is the market cap of Aarti Pharmalabs Ltd?

As of December 26, 2024, Aarti Pharmalabs Ltd has a market capitalization of ₹5725.3, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aarti Pharmalabs Ltd's market capitalization?

Aarti Pharmalabs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aarti Pharmalabs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aarti Pharmalabs Ltd's market capitalization change?

Aarti Pharmalabs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions